• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无选择性中央区颈部清扫术的cN0乳头状甲状腺癌的长期预后

Long-term Outcomes of cN0 Papillary Thyroid Carcinoma without Elective Central Compartment Neck Dissection.

作者信息

Zhou Bo, Huang Hui, Xu Zhengang, Wu Yuehuang, Wang Xiaolei

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):383-388. doi: 10.3881/j.issn.1000-503X.2017.03.014.

DOI:10.3881/j.issn.1000-503X.2017.03.014
PMID:28695810
Abstract

Objective To determine the long-term outcomes of cN0 papillary thyroid carcinoma without elective central compartment neck dissection. Methods The clinical data of 180 patients with clinically lymph node negative papillary thyroid carcinoma who were treated in our center between 2000 and 2005 were retrospectively analyzed. All of these patients did not receive elective central compartment neck dissection. Clinicopathological characteristics including gender,age,surgical range,pathologic type,tumor size,and extrathyroidal extension(ETE)or not were collected. Results After a median follow-up period of 90 months,only one patient died of stroke without tumor. Sixteen patients had tumor recurrence:seven patients had a recurrent disease in residual thyroid tissue,two in the thyroid bed,six in central compartment,eight in lateral cervical compartment,and one in lung. The 10-year overall survival,disease-specific survival,and recurrence-free survival was 99.4%,100%,and 87.9%,respectively. The 10-year accumulative lymph node recurrence rate in central compartment and lateral compartment was 7.8% and 7.0%,respectively. ETE was an independent risk factor for central compartment lymph node recurrence. Male gender(P=0.010)and ETE(P=0.028)were independent risk factors for lateral compartment lymph node recurrence. Conclusions The prognosis of patients with cN0 papillary thyroid carcinoma without elective central compartment neck dissection is good after ten years of follow-up. Male gender and ETE are independent risk factors for lateral compartment lymph node recurrence.

摘要

目的 确定未行选择性中央区颈淋巴结清扫术的cN0期甲状腺乳头状癌的长期预后。方法 回顾性分析2000年至2005年在本中心接受治疗的180例临床淋巴结阴性甲状腺乳头状癌患者的临床资料。所有这些患者均未接受选择性中央区颈淋巴结清扫术。收集患者的临床病理特征,包括性别、年龄、手术范围、病理类型、肿瘤大小以及是否存在甲状腺外侵犯(ETE)。结果 中位随访90个月后,仅1例患者非肿瘤原因死于中风。16例患者出现肿瘤复发:7例患者在残余甲状腺组织复发,2例在甲状腺床复发,6例在中央区复发,8例在侧颈部复发,1例在肺部复发。10年总生存率、疾病特异性生存率和无复发生存率分别为99.4%、100%和87.9%。中央区和侧颈部10年累积淋巴结复发率分别为7.8%和7.0%。ETE是中央区淋巴结复发的独立危险因素。男性(P=0.010)和ETE(P=0.028)是侧颈部淋巴结复发的独立危险因素。结论 对未行选择性中央区颈淋巴结清扫术的cN0期甲状腺乳头状癌患者进行10年随访后的预后良好。男性和ETE是侧颈部淋巴结复发的独立危险因素。

相似文献

1
Long-term Outcomes of cN0 Papillary Thyroid Carcinoma without Elective Central Compartment Neck Dissection.无选择性中央区颈部清扫术的cN0乳头状甲状腺癌的长期预后
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):383-388. doi: 10.3881/j.issn.1000-503X.2017.03.014.
2
[Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].[中央区颈淋巴结清扫术后cN0期甲状腺乳头状癌患者颈部淋巴结复发模式分析]
Zhonghua Zhong Liu Za Zhi. 2015 Oct;37(10):771-5.
3
Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.识别临床淋巴结阴性的乳头状甲状腺癌侧方淋巴结复发的危险因素。
Medicine (Baltimore). 2018 Dec;97(51):e13435. doi: 10.1097/MD.0000000000013435.
4
Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.cN0 期乳头状甲状腺癌中央区颈淋巴结清扫的长期预后
Am J Otolaryngol. 2017 Sep-Oct;38(5):576-581. doi: 10.1016/j.amjoto.2017.06.004. Epub 2017 Jun 14.
5
Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.临床颈淋巴结阴性(cN0)甲状腺乳头状癌预防性中央区颈淋巴结清扫的合理性:还有什么可说的吗?单中心十年经验。
Int J Surg. 2017 May;41 Suppl 1:S40-S47. doi: 10.1016/j.ijsu.2017.01.113.
6
Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.根据中央淋巴结转移风险评分模型和复发预测因素管理 cN0 甲状腺微小乳头状癌患者。
J Endocrinol Invest. 2020 Dec;43(12):1807-1817. doi: 10.1007/s40618-020-01326-1. Epub 2020 Jun 18.
7
Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.识别临床淋巴结阴性但病理为N1a的乳头状甲状腺癌复发的危险因素。
BMC Surg. 2019 Jul 5;19(1):78. doi: 10.1186/s12893-019-0541-5.
8
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
9
Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.经腋后(TARA)入路机器人辅助施行 Sistrunk 手术、甲状腺全切除术和颈淋巴结清扫术治疗甲状舌管囊肿和甲状腺起源的乳头状癌
Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16.
10
Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.甲状腺乳头状癌淋巴结复发的临床病理模式。对手术的影响。
Int J Surg. 2014;12 Suppl 1:S194-7. doi: 10.1016/j.ijsu.2014.05.010. Epub 2014 May 23.

引用本文的文献

1
LncRNA HOTAIR Influences the Growth, Migration, and Invasion of Papillary Thyroid Carcinoma via Affection on the miR-488-5p/NUP205 Axis.长链非编码 RNA HOTAIR 通过影响 miR-488-5p/NUP205 轴影响甲状腺乳头状癌的生长、迁移和侵袭。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820962125. doi: 10.1177/1533033820962125.